ERTUGLIFLOZIN AND SITAGLIPTIN

120 reported adverse events

These side effects are most commonly reported by patients taking ERTUGLIFLOZIN AND SITAGLIPTIN:

# Side effect Count
0 DYSPNOEA 16
1 BRADYCARDIA 15
2 VOMITING 15
3 COVID-19 13
4 COVID-19 PNEUMONIA 12
5 GASTROINTESTINAL HAEMORRHAGE 12
6 BLOOD GLUCOSE INCREASED 10
7 CARDIAC FAILURE 9
8 PRODUCT DOSE OMISSION ISSUE 9
9 HYPERTENSION 6
See all common reactions for ERTUGLIFLOZIN AND SITAGLIPTIN

ERTUGLIFLOZIN AND SITAGLIPTIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PYELOCYSTITIS 1 0.0833
1 ALCOHOL TEST POSITIVE 1 0.0213
2 HYPERGLYCAEMIC CRISIS 1 0.0192
3 HAEMORRHAGIC NECROTIC PANCREATITIS 1 0.0133
4 PANCREATIC DUCT OBSTRUCTION 2 0.0112
5 WOUND NECROSIS 2 0.0042
6 DIABETIC RETINOPATHY 4 0.0012
7 COVID-19 PNEUMONIA 12 0.0010
8 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 4 0.0010
9 CAROTID ARTERIOSCLEROSIS 1 0.0010
See all enriched reactions for ERTUGLIFLOZIN AND SITAGLIPTIN